Dr. Kevin Berger joined CMI in January 2012 as Director of PET/CT. Voted one of top 20 physicians nationwide in molecular imaging, Dr. Berger was one of four physicians to design the first fusion PET/CT scanner, and helped develop first commercial PET/CT. He also developed sodium fluoride PET imaging for Cardinal Health at Michigan State Univeristy, and pioneered quantitative PET brain analysis tools.
After receiving his MD (1994) as well as his undergraduate degree from the University of Michigan, he completed his Diagnostic Radiology Residency, and Neuroradiology Fellowship at Mallinckrodt Institute of Radiology, Washington University, St. Louis. Dr. Berger previously served as assistant professor of Radiology and Director of PET/CT at Michigan State University.
Widely published in PET/CT with over 100 abstracts and articles, Dr. Berger continues to be a leader in his field, overseeing CMI’s participation in an international study on diagnosing patients with memory loss (IDEAS) in 2017, and the ongoing addition of PET/CT to CMI facilities.
A consultant to the National Institutes of Health for PET/MRI development and member of numerous advisory boards, Dr. Berger has also served on speaking bureaus for General Electric, Cardinal Health, and Educational Symposia, and as a member of the ACR appropriateness guidelines committee for neuroradiology. Dr. Berger is licensed to practice medicine in Maryland.